Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoqinglong granules are an oral **traditional Chinese patent medicine** formulation derived from the classical Xiaoqinglong decoction. It is a multi-herb product used mainly for respiratory conditions characterized in traditional Chinese medicine as external wind-cold with internal fluid or phlegm retention, and has been studied clinically as an add-on therapy for asthma and cough-variant asthma. Its pharmacology is **multi-component and not reducible to a single validated molecular target**; proposed effects in the literature include bronchodulatory, anti-inflammatory, antitussive, and immunomodulatory actions. Publicly identifiable sources verify the product name in clinical and publication contexts, but the exact commercial developer or manufacturer for the specific asset named here is not clear from the provided evidence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoqinglong granules.